NCT03848767 is a NA clinical trial of AID System in Type 1 Diabetes Mellitus, sponsored by Eli Lilly and Company.

Who is sponsoring NCT03848767?

NCT03848767 is sponsored by Eli Lilly and Company.

What drugs are being tested in NCT03848767?

Interventions in NCT03848767: AID System, Insulin Lispro.

What condition does NCT03848767 study?

NCT03848767 studies Type 1 Diabetes Mellitus.

Is NCT03848767 still recruiting?

NCT03848767 is currently completed. Last updated 23 April 2019.

Last reviewed 2019-04-23 · How we verify

NCT03848767

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

Completed NA Last updated 23 April 2019

What this trial tests

NA trial testing AID System in Type 1 Diabetes Mellitus in 10 participants. Completed in 1 April 2019.

Timeline

20 February 2019

Primary endpoint
1 April 2019

1 April 2019

Quick facts

Lead sponsor	Eli Lilly and Company
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	10
Start date	20 February 2019
Primary completion	1 April 2019
Estimated completion	1 April 2019
Sites	1 location across United States

Drugs / interventions tested

AID System
Insulin Lispro (INSULIN LISPRO) — full drug profile →

Conditions studied

Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →

Sponsor

Eli Lilly and Company — full company profile →

Who can join

Adults 18 to 65, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system during meal challenges.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method.
Sugumar V, Ang KP, Alshanon AF, Sethi G, et al · · 2022 · cited 14× · PMID 35890301 · DOI 10.3390/pharmaceutics14071406
56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 September 2020.
· 2020 · cited 9× · PMID 32840677 · DOI 10.1007/s00125-020-05221-5

Verify or expand the search:

Other trials of AID System

Trials testing the same drug.

NCT03890003 — A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes · NA · completed
NCT03849612 — A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus · NA · completed
NCT03743285 — A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D) · NA · completed
NCT03367390 — A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) · Phase 1 · completed

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

NCT07142252 — Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus · Phase 2 · recruiting
NCT07296276 — Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM · NA · recruiting
NCT07409701 — Gamification Intervertion in Children With Type 1 Diabetes · NA · recruiting
NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
NCT07434154 — Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults · recruiting

Other Eli Lilly and Company trials

Trials by the same sponsor.

NCT07533006 — A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) · Phase 2 · not yet recruiting
NCT07533019 — A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo · Phase 2 · not yet recruiting
NCT07247357 — A Study of LY4064809 in Healthy Adult Chinese Participants · Phase 1 · completed
NCT07124013 — A Study of Olomorasib (LY3537982) in Healthy Japanese Participants · Phase 1 · completed
NCT07030127 — A Study of LY3985863 in Healthy Participants · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03848767 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eli Lilly and Company
Last refreshed: 23 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03848767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing